| Description | Pifoxime, a non-steroidal anti-inflammatory agent (NSAID) and COX-1/2 inhibitor, exhibits anti-inflammatory properties, making it useful in neuropsychiatric research. |
| In vitro | TT-10 (10 μmol/L ; 48 h) significantly promoted cell cycle activation and cell division of human induced pluripotent stem cell (hiPSC) derived cardiomyocytes (hiPSCM).[1] |
| In vivo | TT-10 (2 μM, 10 μM, 20 μM, or 100 μM ; 48 h ; intraperitoneal injections) was administered to infarcted mouse hearts, the treatment promoted cardiomyocyte proliferation and was associated with declines in infarct size 1 week after administration, but cardiac function worsened at later time points.[2] |
| molecular weight | 276.33 |
| Molecular formula | C15H20N2O3 |
| CAS | 31224-92-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |